Student Loan Repayment for Orthopedic Surgeons: The 2026 Decision Framework

The federal loan landscape changed significantly in early 2026 — the SAVE plan ended, a new RAP plan arrives July 1, and PSLF employer rules are also shifting. For orthopedic surgeons with $200K–$350K in medical school debt, the correct repayment strategy depends almost entirely on one variable: hospital-employed or private practice?

Start here: your practice model determines your loan strategy

Most loan repayment guides for physicians are built around income-driven repayment and Public Service Loan Forgiveness. But for orthopedic surgeons, the analysis is more direct:

• Private practice surgeon — PSLF is almost never available (private medical groups are not 501(c)(3) organizations). The strategy is to refinance and pay off aggressively using a fraction of attending income. A spine surgeon earning $1.0M can pay off $280K in debt in under three years.
• Hospital-employed at a nonprofit — PSLF may make sense. An academic surgeon or trauma surgeon at a 501(c)(3) system who planned to stay hospital-employed regardless should evaluate whether pursuing PSLF produces net savings relative to accelerated payoff.
• Still deciding at fellowship — Do not refinance yet. Stay on an IDR plan during training, keep PSLF eligibility open, and make the refinancing decision when your practice model is settled.

The 2026 federal loan landscape

The loan environment has changed substantially in early 2026. Here is the current state:

SAVE plan ended March 10, 2026

The Saving on a Valuable Education (SAVE) plan — which offered lower discretionary income thresholds and an interest subsidy — was struck down by federal courts and officially ended March 10, 2026.¹ Borrowers who were enrolled in SAVE have been removed from it and are being transitioned to other plans. If your servicer shows you on SAVE as of 2026, you are in a processing queue — contact your servicer and enroll in Income-Based Repayment (IBR) before interest resumes.

IBR: the current IDR option for existing borrowers

For loans disbursed before July 1, 2026, Income-Based Repayment (IBR) is currently the most durable income-driven repayment option.² IBR payments are 10% of discretionary income (15% for borrowers with older loans), capped at the amount you would owe under a 10-year Standard Repayment Plan. For high-income orthopedic surgeons not pursuing forgiveness, that cap means IBR offers little benefit over standard repayment — you hit the cap immediately once you are earning attending-level income. The value of IBR is almost entirely concentrated during training, when your income is low and payments are minimal.

IBR forgiveness at 20–25 years is taxable as ordinary income at the federal level — unlike PSLF. For surgeons not pursuing PSLF, IBR forgiveness is not typically the goal; it is a backstop that rarely triggers.

RAP: arrives July 1, 2026 for new borrowers

The Repayment Assistance Plan (RAP) — created under the One Big Beautiful Bill Act — launches July 1, 2026. For loans first disbursed on or after that date, RAP will be the primary IDR option.¹ If you are a current fellow or resident with existing loans, RAP does not apply to your current balance; IBR remains your IDR option. For any new borrowing you take on after July 1, 2026 (unusual but possible if you are refinancing or taking on additional graduate school debt), RAP will govern IDR options.

PSLF remains available — with July 1, 2026 employer rule changes

Public Service Loan Forgiveness has not been eliminated. It continues to offer 120 qualifying payments on an IDR plan while employed full-time at a qualifying employer, with forgiveness being federal income tax-free. Starting July 1, 2026, the Department of Education finalized revised rules that allow disqualification of employers engaged in activities with a "substantial illegal purpose" — but the practical effect on standard nonprofit hospitals, academic medical centers, VA facilities, and county health systems is minimal.³ Eligible 501(c)(3) hospital systems remain qualifying PSLF employers.

PSLF math for hospital-employed orthopedic surgeons

PSLF is worth analyzing seriously for orthopedic surgeons who genuinely plan to remain hospital-employed at a qualifying nonprofit throughout their career. The math works as follows for a realistic scenario:

Starting position: Fellowship graduate, $265K in federal student loan debt at 7% average rate, entering a nonprofit academic trauma position.

• Years 1–5 (residency/fellowship): On IBR with ~$65K–$75K resident/fellow income, monthly payment ~$350–$500/month. Total paid: ~$25K. Qualifying PSLF payment count: 60.
• Years 6–10 (attending at nonprofit): Income $650K. IBR payment hits its cap — the equivalent of a 10-year standard payment on the loan balance (now grown to roughly $330K after unpaid interest capitalization). Monthly payment ~$3,800–$4,200/month. Total paid: ~$235K. Qualifying payment count reaches 120.
• PSLF forgiveness at year 10: Remaining balance (~$180K–$220K) forgiven tax-free.
• Total paid over 10 years: approximately $260K on a $265K debt. The interest that accrued during training and the remaining principal get wiped at forgiveness.

Now compare to a private practice spine surgeon with the same debt who refinances at attending:

• Refinances $265K at 5.5% over 5 years: monthly payment ~$5,080. Total paid: ~$305K.
• Can also pay more aggressively — at $1.1M income, allocating $15K/month pays off the loan in under 2 years with ~$283K total.

The forgiveness advantage for the academic surgeon is real — but it exists alongside a meaningful income gap. Academic attending orthopedic surgeons typically earn $600K–$800K; private practice surgeons in the same subspecialty often earn $900K–$1.5M+. The loan savings from PSLF ($40K–$80K in this scenario) do not offset a multi-hundred-thousand dollar annual income differential. PSLF is worth pursuing for surgeons who want academic or hospital-employed careers on their own merits. It is not worth taking a job you would not otherwise want in order to pursue loan forgiveness.

The refinancing strategy for private practice surgeons

Orthopedic surgeons entering private practice should refinance federal loans after their income is confirmed and their employment contract is signed — not before, and not during residency/fellowship. Refinancing to a private lender converts federal loans to private loans permanently, eliminating access to PSLF and IDR plans. The window to decide is when you accept an offer.

What to look for in a refinance

• Fixed vs variable rate: With attending incomes, most orthopedic surgeons can aggressively pay off debt in 2–5 years. Variable rates can be advantageous on a short payoff horizon if rates are favorable, but fixed rates eliminate rate risk if payoff takes longer than expected (partnership track uncertainty, practice transitions).
• Forbearance provisions: If your early-career practice situation is volatile (new group, buy-in timeline unclear), look for lenders with meaningful hardship forbearance. Disability forbearance terms matter too — check whether a disability makes payments pause until your DI policy kicks in.
• No prepayment penalty: All major physician refinance lenders offer this, but verify. At orthopedic surgeon income levels, you should expect to pay this off faster than the stated term.

Aggressive payoff vs investing the difference

At a refinanced rate of 5–6%, the expected after-tax return on investing excess cash (in a diversified portfolio) is higher over a long horizon — but not necessarily by enough to justify the risk-adjusted comparison for a large, certain liability. The correct answer depends on your specific rate, marginal tax bracket, and risk tolerance.

A reasonable middle path: direct 50% of excess cash flow toward loan payoff and 50% toward tax-advantaged retirement contributions. At orthopedic surgeon income levels, you should be maxing out the 401(k)/cash balance/backdoor Roth stack first (see our retirement tax stacking guide), then directing remaining cash toward loans. Paying off $265K in 24–36 months on a $1.0M income while also funding a cash balance plan is entirely achievable.

The training-period strategy: what to do during residency and fellowship

During residency (typically 5 years for ortho) and fellowship (1–2 additional years), the correct strategy is almost always to stay on IBR and make minimum IDR payments. Here is why:

• IBR payments during training are very low. On a $70K resident salary, IBR payments are roughly $300–$450/month — far less than what interest accrues. Your balance will grow. This is acceptable.
• Refinancing during training locks you out of PSLF — a decision you do not need to make yet. Most orthopedic surgeons do not know their final practice model at the start of residency.
• Applying for PSLF now costs nothing. Submit the PSLF Employment Certification form each year during residency if you are at a nonprofit training program. These qualifying payments count toward the 120 total even if you eventually leave for private practice — they are not lost, just unused if you refinance later.
• The PAYE plan ended. As of 2026, PAYE has been closed to new enrollees. If you are starting an IDR plan fresh, IBR is your option.

The one exception: if you have strong evidence you will join private practice immediately after fellowship and you have high-rate loans (above 7.5–8%), there may be an argument for early refinancing. Get a fee-only financial advisor to model the specific numbers before refinancing during training — the decision is irreversible.

The debt numbers for orthopedic surgeons

Average medical school debt for 2025 graduates is approximately $223,000 for medical school alone; including undergraduate borrowing, the median total education debt is around $247,000.⁴ But orthopedic surgeons tend to have higher debt than the specialty average for several reasons: the pipeline is heavily drawn from competitive private medical schools with high tuition, and the training duration (5-year residency + 1-2 year fellowship) means 6–7 more years before loan repayment begins in earnest.

In practice, many orthopedic fellowship graduates begin attending practice with $280K–$350K in total student loan debt. At orthopedic surgeon income levels — MGMA 2024 survey data shows median orthopedic surgery compensation at $686K (general) to $883K (spine) — this balance is 0.3–0.5× one year's gross income. The financial burden, while real, is proportionally lower than for most other medical specialties. Surgeons, anesthesiologists, and dermatologists have the shortest debt payoff horizons of any medical specialty — typically 3–5 years at aggressive repayment — because of income-to-debt ratios.⁴

The ASC and practice equity complication

One uniquely orthopedic wrinkle: early-career private practice surgeons are often invited into ASC co-investment within the first 1–3 years of partnership. Buy-ins can range from $150K to $1M+ depending on the facility. This competes directly with aggressive loan payoff for the same cash flow.

The general rule: ASC investment returns (see our ASC investment calculator) frequently exceed the after-tax interest cost of carrying student loans at current rates. If you have a legitimate ASC investment opportunity with an attractive distribution yield, you may be better served funding the ASC buy-in while carrying the student debt longer at a refinanced rate. This is a specific case where "pay off debt aggressively first" is not always the optimal path. Model both scenarios with real numbers before deciding.